ABIN189747
antibody from antibodies-online
Targeting: MLXIPL
bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN189747 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-MLX Interacting Protein-Like (MLXIPL) (AA 800-852), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- AA 800-852, C-Term
- Vial size
- 0.025 mL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat.
Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.
Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist.
Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Erhuma A, Salter AM, Sculley DV, Langley-Evans SC, Bennett AJ
American journal of physiology. Endocrinology and metabolism 2007 Jun;292(6):E1702-14
American journal of physiology. Endocrinology and metabolism 2007 Jun;292(6):E1702-14
Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.
Wang Y, Botolin D, Xu J, Christian B, Mitchell E, Jayaprakasam B, Nair MG, Peters JM, Busik JV, Olson LK, Jump DB
Journal of lipid research 2006 Sep;47(9):2028-41
Journal of lipid research 2006 Sep;47(9):2028-41
Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist.
Xu J, Christian B, Jump DB
The Journal of biological chemistry 2006 Jul 7;281(27):18351-62
The Journal of biological chemistry 2006 Jul 7;281(27):18351-62
Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C
Diabetes 2006 Aug;55(8):2159-70
Diabetes 2006 Aug;55(8):2159-70
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC